2-Hydroxy-5-Methylpyridine CAS 1003-68-5 Kuchena ≥99.0% Pirfenidone Intermediate Factory

Tsanangudzo Pfupi:

Zita reKemikari: 2-Hydroxy-5-Methylpyridine

Mazwi akafanana: 5-Methyl-2(1H)-Pyridinone

CAS: 1003-68-5

Kuchena: ≥99.0%

Chitarisiko: Kunze-Kuchena kune Yellow Crystalline Powder

Pakati pePirfenidone (CAS: 53179-13-8) kurapa Idiopathic Pulmonary Fibrosis (IPF)

E-Mail: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Tsanangudzo:

Manufacturer Supply, High Purity, Commercial Production
Zita reKemikari: 2-Hydroxy-5-Methylpyridine
CAS: 1003-68-5

Chemical Properties:

Chemical Name 2-Hydroxy-5-Methylpyridine
Mashoko anoreva zvakafanana 5-Methyl-2(1H)-Pyridinone;2-Hydroxy-5-Picoline;6-Hydroxy-3-Picoline;5-Methyl-2-Pyridinol
Nhamba yeCAS 1003-68-5
Nhamba yeCAT RF-PI549
Stock Status MuStock, Kugadzirwa Kunokwira Kusvika Matani
Molecular Formula C6H7NO
Molecular Weight 109.13
Melting Point 183.0 kusvika 187.0 ℃ (lit.)
Solubility Soluble muMethanol
Brand Ruifu Chemical

Zvinotsanangurwa:

Item Zvinotsanangurwa
Chitarisiko Off-White kusvika Yellow Crystalline Powder
Kuchena ≥99.0%
Kunyorova Kwemukati (KF) ≤0.50%
Residue paIgnition ≤0.50%
Chero Kusachena Kumwe ≤0.50%
Zvose Zvisina Kuchena ≤1.00%
Residual Solvents
n-Butanol ≤0.30%
Ethanol ≤0.30%
Test Standard Enterprise Standard
Usage Pakati pePirfenidone (CAS: 53179-13-8)

Package & Kuchengeta:

Package: Bhodhoro, Aluminium foil bag, 25kg/Cardboard Drum, kana zvinoenderana nezvinodiwa nemutengi.

Storage Condition:Chengetedza mumidziyo yakavharwa panzvimbo inotonhorera uye yakaoma;Dzivirira kubva kuchiedza uye unyoro

Zvakanakira:

1

FAQ:

Application:

2-Hydroxy-5-Methylpyridine (CAS: 1003-68-5) inoshandiswa semishonga yepakati yePirfenidone (CAS: 53179-13-8).Pirfenidone (PFD) rudzi rutsva rwepyridine ketones ine wide-spectrum anti-fibrotic effect, inokwanisa kudzivirira nekudzorera kuumbwa kwefibrosis uye vanga.Yakapinda mumusika muShionogi, Japan muna 2008 uye yakabvumidzwa neUS chikafu neDrug Administration.Ndiwo mushonga wekutanga wakapfuura nechikamu chechitatu chekiriniki miedzo (kusanganisira kudzokorora, randomized, uye placebo-control) iyo inoratidza kushanda kwayo mukurapa idiopathic pulmonary fibrosis (IPF);uyezve, mushonga uyu unoshanda zvakanaka mukurapa zvimwe zvirwere zvefibrotic senge renal interstitial fibrosis uye chiropa fibrosis.

Nyora meseji yako pano ugotitumira